HC HealthLynked Corp Stock: price and insider trades · United States · SEC (Form 4)Track the HealthLynked Corp share price and the full management transaction log of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, HealthLynked Corp has recorded 25 insider filings. Market capitalisation: €8.7m. The latest transaction was reported on 24 June 2024 (Acquisition). Among the most active insiders: GASPARINI ROBERT P. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 June 2024
All Executives25 Thresholds0 Prospectus0 Other0
Declarations 25 total
▲ Chief Financial Officer · Executives · 20 Jun 2024
33,667 shares @ US$0.08 100.0% of flow Common stock SEC:0001213900-24-055207:0
Canonical exit: 18 Sept 2024 (T+90) ◆ Director · Executives · 27 Sept 2023
408,163 shares 0Common Stock SEC:0001013762-23-002528:0
◆ Director · Executives · 27 Sept 2023
408,163 shares 0Common Stock SEC:0001013762-23-002527:0
◆ Director · Executives · 27 Sept 2023
408,163 shares 0Common Stock SEC:0001013762-23-002530:0
◆ Director · Executives · 27 Sept 2023
408,163 shares 0Common Stock SEC:0001013762-23-002529:0
◆ Chief Executive Officer · Executives · 27 Jan 2023
50,000 shares 0Common stock SEC:0001213900-23-006421:0
◆ Chief Financial Officer · Executives · 27 Jan 2023
50,000 shares 0Common stock SEC:0001213900-23-006422:0
◆ Director · Executives · 8 Dec 2022
536,193 shares 0Common Stock SEC:0001213900-22-079100:0
◆ Director · Executives · 8 Dec 2022
536,193 shares 0Common Stock SEC:0001213900-22-079102:0
◆ Director · Executives · 8 Dec 2022
536,193 shares 0Common Stock SEC:0001213900-22-079099:0
◆ Chief Financial Officer · Executives · 20 Oct 2022
400,000 shares 0Common stock SEC:0001213900-22-065570:0
◆ Chief Financial Officer · Executives · 21 Dec 2021
2,000 shares 0Common stock SEC:0001213900-22-003088:0
◆ Chief Executive Officer · Executives · 21 Dec 2021
2,000 shares 0Common stock SEC:0001213900-22-003090:0
◆ Director · Executives · 22 Nov 2021
74,766 shares 0Common Stock SEC:0001213900-21-061947:0
◆ Director · Executives · 22 Nov 2021
74,766 shares 0Common Stock SEC:0001213900-21-061949:0
◆ Director · Executives · 22 Nov 2021
74,766 shares 0Common Stock SEC:0001213900-21-061950:0
◆ Director · Executives · 22 Nov 2021
74,766 shares 0Common Stock SEC:0001213900-21-061952:0
◆ Director · Executives · 12 Nov 2021
68,942 shares 0Common Stock SEC:0001213900-21-060016:0
◆ Director · Executives · 12 Nov 2021
68,942 shares 0Common Stock SEC:0001213900-21-060015:0
◆ Director · Executives · 12 Nov 2021
68,942 shares 0Common Stock SEC:0001213900-21-060058:0
◆ Director · Executives · 12 Nov 2021
68,942 shares 0Common Stock SEC:0001213900-21-060022:0
● Director · Executives · 21 Jul 2021
312,250 shares @ US$0.10 0.45% mcap 50.0% of flow Common Stock SEC:0001213900-21-049362:0
◆ Director · Executives · 30 Apr 2021
289,694 shares 0Common Stock SEC:0001213900-21-024484:0
◆ Director · Executives · 30 Apr 2021
354,234 shares 0Common Stock SEC:0001213900-21-024481:0
◆ Director · Executives · 30 Apr 2021
81,288 shares 0Common Stock SEC:0001213900-21-024487:0
关于 HealthLynked Corp HealthLynked Corp.(股票代码:HLYK)是一家在美国上市的医疗保健技术和服务公司。根据最新审查的文件,其普通股在 OTCQB 报价,而该公司已申请在纳斯达克资本市场上市,目标是在 2026 年完成过渡。HealthLynked 总部位于佛罗里达州那不勒斯,并在内华达州注册成立。对于法国、比利时和瑞士的投资者而言,该公司最好被理解为一个小型医疗保健平台,采用数字健康软件和直接临床运营相结合的混合模式。([sec.gov](https://www.sec.gov/Archives/edgar/data/1680139/000121390026013824/ea0275639-s1_health.htm))
HealthLynked 的建立围绕着 Michael Dent 博士的愿景,他是一位与 NeoGenomics 创立相关的医生兼企业家。该公司成立于 2014 年,从最初的医疗保健网络概念发展成为一个更广泛的平台,旨在改善患者和提供者之间的医疗信息交流。其既定使命是通过实现准确的数据传输、更好的实践工作流程、改善医疗服务可及性以及更协调的临床决策来提高医疗保健效率。([healthlynked.com](https://www.healthlynked.com/about-us/?utm_source=openai))
该业务围绕两个核心部门构建。数字医疗保健部门以 HealthLynked Network 为中心,这是一个基于云的平台,用于医疗记录管理、预约安排、远程医疗和礼宾式医疗保健协调。医疗服务部门包括在佛罗里达州运营的医疗诊所,包括那不勒斯功能医学中心、那不勒斯礼宾护理和无限美容增强;该公司还在 2025 年 10 月出售了其 Bridging the Gap 物理治疗诊所。这种结构使 HealthLynked 拥有软件支持的患者参与和现实世界临床交付的罕见组合。([sec.gov](https://www.sec.gov/Archives/edgar/data/1680139/000121390025026262/R8.htm))
从竞争角度来看,HealthLynked 仍然是一个发展阶段或新兴增长的故事,而不是一个规模化的医疗保健平台。其投资案例取决于它能否将其网络、软件功能和本地实践足迹转化为经常性收入和更广泛的采用。该公司继续将 HealthLynked Network 定位为一种可以改善患者与提供者连接的工具,同时还支持通过 MedOfficeDirect 进行医疗产品分销等辅助收入流。([investors.healthlynked.com](https://investors.healthlynked.com/presstype/healthlynked-completes-acquisition-of-medofficedirect-llc-adding-discounted-medical-supplies-for-patient-members-and-healthcare-providers/?utm_source=openai))
最近的发展很重要。2025 年 2 月,HealthLynked 强调推出了其人工智能驱动的医疗保健指导功能 ARI,以及旨在改善患者参与的更广泛产品增强。2025 年 11 月,该公司宣布了一项咨询协议,以支持纳斯达克上市路线图,其 2026 年 2 月的招股说明书仍将该股票描述为 OTCQB 报价,同时声明纳斯达克资本市场上市准备工作正在进行中。这些公告表明管理层正在寻求产品扩张和资本市场重新定位。([sec.gov](https://www.sec.gov/Archives/edgar/data/1680139/000121390025009700/ea022973501ex99-2_health.htm))